75+ Scientific Articles and Nutranize Zone Ingredients

Based on scientific evidence
Every ingredient in Nutranize® Zone supports prednisone nutrient repletion.*
Zone counterbalances the effects of prednisone in depleting nutrients or interfering with the metabolism of nutrients.* Prednisone causes nutrient depletion of 9+ nutrients. Dr. Megan created a dietary supplement especially for people on prednisone, Nutranize Zone for Prednisone, to give back the nutrients prednisone steals.
Find 75+ Scientific Articles Below
Click on the Zone ingredient name below to find a list of studies showing nutrient depletion caused by prednisone. The nutrients that prednisone steals from your body include calcium, vitamin D, chromium, magnesium, potassium, folic acid, melatonin, vitamins A, C, and K, and are shown below with a star (*) next to the nutrient’s name. Ingredients without a star are included to support the needs of people on prednisone.
Organized Alphabetically by Ingredient Name in Nutranize Zone:
- Gupta M, Rumman M, Singh B, Mahdi AA, Pandey S. Berberine ameliorates glucocorticoid-induced hyperglycemia: an in vitro and in vivo study. Naunyn Schmiedebergs Arch Pharmacol. 2024 Mar;397(3):1647-1658. doi: 10.1007/s00210-023-02703-2. Epub 2023 Sep 14. PMID: 37704773.
- Zhang Y, Li X, Zou D, et al. Treatment of type 2 diabetes and dyslipidemia with the natural plant alkaloid berberine. J Clin Endocrinol Metab. 2008 Jul;93(7):2559-65. doi: 10.1210/jc.2007-2404. Epub 2008 Apr 8. PMID: 18397984; DOI: 10.1210/jc.2007-2404.
- Dong H, Wang N, Zhao L, Lu F. Berberine in the treatment of type 2 diabetes mellitus: a systemic review and meta-analysis. Evid Based Complement Alternat Med. 2012;2012:591654. PMID: 23118793; PMCID: PMC3478874; DOI: 10.1155/2012/591654.
- Yin J, Xing H, and Ye J. Efficacy of berberine in patients with type 2 diabetes mellitus. Metabolism 2008;57(5):712-717. PMID: 18442638; PMCID: PMC2410097; DOI: 10.1016/j.metabol.2008.01.013.
- Zhang H, Wei J, Xue R, et al. Berberine lowers blood glucose in type 2 diabetes mellitus patients through increasing insulin receptor expression. Metabolism 2010;59(2):285-292. PMID: 19800084; DOI: 10.1016/j.metabol.2009.07.029.
- Chekalina SI, Umurzakova RZ, Saliev KK, et al. Gematologiia i Transfuziologiia 1994;39(5):33-35. PMID: 7896030.
- Panigrahi A, Mohanty S. Efficacy and safety of Berberine on glycemic control in patients with prediabetes: double-blind, placebo-controlled, and randomized pilot trial. BMC Endocr Disord. 2023 Sep 7;23(1):190. doi: 10.1186/s12902-023-01442-y. PMID: 37679692; PMCID: PMC10483788.
- Kong W, Wei J, Abidi P, et al. Berberine is a novel cholesterol-lowering drug working through a unique mechanism distinct from statins. Nat Med. 2004 Dec;10(12):1344-51. doi: 10.1038/nm1135. Epub 2004 Nov 7. PMID: 15531889.
- Yang J, Yin J, Gao H, et al. Berberine improves insulin sensitivity by inhibiting fat store and adjusting adipokines profile in human preadipocytes and metabolic syndrome patients. Evid Based Complement Alternat Med. 2012;2012:363845. doi: 10.1155/2012/363845. Epub 2012 Mar 8. PMID: 22474499; PMCID: PMC3310165.
- Pérez-Rubio KG, González-Ortiz M, Martínez-Abundis E, et al. Effect of berberine administration on metabolic syndrome, insulin sensitivity, and insulin secretion. Metab Syndr Relat Disord. 2013 Oct;11(5):366-9. doi: 10.1089/met.2012.0183. Epub 2013 Jun 28. PMID: 23808999.
- Cao C, Su M. Effects of berberine on glucose-lipid metabolism, inflammatory factors and insulin resistance in patients with metabolic syndrome. Exp Ther Med. 2019 Apr;17(4):3009-3014. doi: 10.3892/etm.2019.7295. Epub 2019 Feb 22. PMID: 30936971; PMCID: PMC6434235.
- Lee YS, Kim WS, Kim KH, et al. Berberine, a natural plant product, activates AMP-activated protein kinase with beneficial metabolic effects in diabetic and insulin-resistant states. Diabetes. 2006 Aug;55(8):2256-64. doi: 10.2337/db06-0006. PMID: 16873688.
- Wang YN, Liu X, He Y, et al. Berberine May Correct Corticosteroid Resistance Induced By Gut Microbiota Dysbiosis in Immune Thrombocytopenia. Blood. 2018;132(Supp 1):3769. DOI: https://doi.org/10.1182/blood-2018-99-113983
- Brusq JM, Ancellin N, Grondin P, et al. Inhibition of lipid synthesis through activation of AMP kinase: an additional mechanism for the hypolipidemic effects of berberine. J Lipid Res. 2006 Jun;47(6):1281-8. doi: 10.1194/jlr.M600020-JLR200. Epub 2006 Feb 28. PMID: 16508037.
- Jiang D, Wang D, Zhuang X, et al. Berberine increases adipose triglyceride lipase in 3T3-L1 adipocytes through the AMPK pathway. Lipids Health Dis. 2016 Dec 9;15(1):214. doi: 10.1186/s12944-016-0383-4. PMID: 27938388; PMCID: PMC5148888.
- Humphrey MB, Russell L, Danila MI, et al. 2022 American College of Rheumatology Guideline for the Prevention and Treatment of Glucocorticoid-Induced Osteoporosis. Arthritis Rheumatol. 2023 Dec;75(12):2088-2102. doi: 10.1002/art.42646. Epub 2023 Oct 16. PMID: 37845798.
- Allen CS, Yeung JH, Vandermeer B, Homik J. Bisphosphonates for steroid-induced osteoporosis. Cochrane Database Syst Rev. 2016 Oct 5;10(10):CD001347. doi: 10.1002/14651858.CD001347.pub2. PMID: 27706804; PMCID: PMC6461188.
- Homik J, Suarez-Almazor ME, Shea B, et al. Calcium and vitamin D for corticosteroid-induced osteoporosis. Cochrane Database Syst Rev. 2000;(2):CD000952. PMID: 10796394; DOI: 10.1002/14651858.CD000952.
- Kusuda Y, Kondo Y, Miyagi Y, et al. Long-term dexamethasone treatment diminishes store-operated Ca2+ entry in salivary acinar cells. Int J Oral Sci. 2019 Jan 3;11(1):1. doi: 10.1038/s41368-018-0031-0. PMID: 30602784; PMCID: PMC6315037.
- Briot K, Roux C. Glucocorticoid-induced osteoporosis. RMD Open. 2015 Apr 8;1(1):e000014. PMID: 26509049; PMCID: PMC4613168; DOI: 10.1136/rmdopen-2014-000014.
- Hoes JN, Bultink IE, Lems WF. Management of osteoporosis in rheumatoid arthritis patients. Expert Opin Pharmacother. 2015 Mar;16(4):559-71. PMID: 25626121; DOI: 10.1517/14656566.2015.997709.
- Mohn ES, Kern HJ, Saltzman E, et al. Evidence of Drug-Nutrient Interactions with Chronic Use of Commonly Prescribed Medications: An Update. Pharmaceutics. 2018;10(1)pii: E36. PMID: 29558445; PMCID: PMC5874849; DOI: 10.3390/pharmaceutics10010036.
- Cappuccio FP, Elliott P, Allender PS, et al. Epidemiologic association between dietary calcium intake and blood pressure: a meta-analysis of published data. Am J Epidemiol. 1995;142(9):935-945. PMID: 7572974.
- Caan B, Neuhouser M, Aragaki A, et al. Calcium plus vitamin D supplementation and the risk of postmenopausal weight gain. Arch Intern Med. 2007;167:893-902. PMID: 17502530; DOI: 10.1001/archinte.167.9.893.
- Buist RA. Drug-Nutrient Interactions–An Overview. Int Clin Nutr Rev. 1984;4(3):114-121.
- Van Staa TP, Leufkens HG, Cooper C. The Epidemiology of Corticosteroid-Induced Osteoporosis: A Meta-analysis. Osteoporos Int. 2002;13:777–787. doi: 10.1007/s001980200108. PMID: 12378366.
- Hahn TJ, Halstead LR, Baran DT. Effects off short term glucocorticoid administration on intestinal calcium absorption and circulating vitamin D metabolite concentrations in man. J Clin Endocrinol Metab. 1981;52:111–115. doi: 10.1210/jcem-52-1-111. PMID: 6969728
- Buckley LM, Leib ES, Cartularo KS, et al. Calcium and vitamin D3 supplementation prevents bone loss in the spine secondary to low-dose corticosteroids in patients with rheumatoid arthritis. A randomized, double-blind, placebo-controlled trial. Ann. Intern. Med. 1996;125:961–968. doi: 10.7326/0003-4819-125-12-199612150-00004. PMID: 8967706
- Adachi JD, Bensen WG, Bianchi F, et al. Vitamin D and calcium in the prevention of corticosteroid induced osteoporosis: A 3 year follow up. J. Rheumatol. 1996;23:995–1000. PMID: 8782129
- Bijlsma JW, Raymakers JA, Mosch C, et al. Effect of oral calcium and vitamin D on glucocorticoid-induced osteopenia. Clin Exp Rheumatol. 1988;6:113–119. PMID: 3180536 Google Scholar
- Ringe JD, Cöster A, Meng T, et al. Treatment of glucocorticoid-induced osteoporosis with alfacalcidol/calcium versus vitamin D/calcium. Calcif Tissue Int. 1999;65:337–340. doi: 10.1007/s002239900708. PMID: 10485988 Google Scholar
- Khan A, Safdar M, Ali Khan M, et al. Cinnamon improves glucose and lipids of people with type 2 diabetes. Diabetes Care 2003;26:3215-8. PMID: 14633804.
- Crawford P. Effectiveness of cinnamon for lowering hemoglobin A1C in patients with type 2 diabetes: a randomized, controlled trial. J Am Board Fam Med 2009;22:507-12. PMID: 19734396; DOI: 10.3122/jabfm.2009.05.080093.
- Nayak IN, Chinta R, Jetti R. Anti-Atherosclerotic Potential of Aqueous Extract of Cinnamomum Zeylanicum Bark against Glucocorticoid Induced Atherosclerosis in Wistar Rats. J Clin Diagn Res. 2017 May;11(5):FC19-FC23. doi: 10.7860/JCDR/2017/23910.9864. Epub 2017 May 1. PMID: 28658798; PMCID: PMC5483700.
- Blevins SM, Leyva MJ, Brown J, et al. Effect of cinnamon on glucose and lipid levels in non insulin-dependent type 2 diabetes. Diabetes Care 2007;30:2236-7. PMID: 17563345; DOI:10.2337/dc07-0098.
- Akilen R, Tsiami A, Devendra D, et al. Glycated haemoglobin and blood pressure-lowering effect of cinnamon in multi-ethnic Type 2 diabetic patients in the UK: a randomized, placebo-controlled, double-blind clinical trial. Diabet Med 2010;27(10):1159-1167. PMID: 20854384; DOI: 10.1111/j.1464-5491.2010.03079.x.
- Asbaghi O, Fatemeh N, Mahnaz RK, et al. Effects of chromium supplementation on glycemic control in patients with type 2 diabetes: a systematic review and meta-analysis of randomized controlled trials. Pharmacol Res. 2020 Nov;161:105098. doi: 10.1016/j.phrs.2020.105098. Epub 2020 Jul 28. PMID: 32730903.
- Ravina A, Slezak L, Mirsky N, et al. Reversal of corticosteroid-induced diabetes mellitus with supplemental chromium. Diabet Med. 1999;16:164-7. PMID: 10229312.
- Ravina A, Slezak L, Mirsky N, et al. Control of steroid-induced diabetes with supplemental chromium. J Trace Elem Exper Med. 1999;12(4):375-378. DOI: https://doi.org/10.1002/(SICI)1520-670X(1999)12:4<375::AID-JTRA11>3.0.CO;2-R.
- Paiva AN, Lima JG, Medeiros AC, et al. Beneficial effects of oral chromium picolinate supplementation on glycemic control in patients with type 2 diabetes: A randomized clinical study. J Trace Elem Med Biol. 2015;32:66-72. PMID: 26302914; DOI: 10.1016/j.jtemb.2015.05.006.
- Suksomboon N, Poolsup N, Yuwanakorn A. Systematic review and meta-analysis of the efficacy and safety of chromium supplementation in diabetes. J Clin Pharm Ther. 2014 Jun;39(3):292-306. PMID: 24635480; DOI: 10.1111/jcpt.12147.
- Press RI, Geller J, Evans GW. The effect of chromium picolinate on serum cholesterol and apolipoprotein fractions in human subjects. West J Med. 1990 Jan;152(1):41-5. PMID: 2408233; PMCID: PMC1002252.
- Tian H, Guo X, Wang X, et al. Chromium picolinate supplementation for overweight or obese adults. Cochrane Database Syst Rev. 2013 Nov 29;(11):CD010063. PMID: 24293292; DOI: 10.1002/14651858.CD010063.pub2.
- Sala M, Breithaupt L, Bulik CM, et al. A Double-Blind, Randomized Pilot Trial of Chromium Picolinate for Overweight Individuals with Binge-Eating Disorder: Effects on Glucose Regulation. J Diet Suppl. 2017 Mar 4;14(2):191-199. PMID: 27835050.
- Docherty JP, Sack DA, Roffman M, et al. A double-blind, placebo-controlled, exploratory trial of chromium picolinate in atypical depression: effect on carbohydrate craving. J Psychiatr Pract. 2005 Sep;11(5):302-14. PMID: 16184071.
- Mohn ES, Kern HJ, Saltzman E, et al. Evidence of Drug-Nutrient Interactions with Chronic Use of Commonly Prescribed Medications: An Update. Pharmaceutics. 2018;10(1)pii: E36. PMID: 29558445; PMCID: PMC5874849; DOI: 10.3390/pharmaceutics10010036.
- Henderson AM, Aleliunas RE, Loh SP, Khor GL, Harvey-Leeson S, Glier MB, Kitts DD, Green TJ, Devlin AM. l-5-Methyltetrahydrofolate Supplementation Increases Blood Folate Concentrations to a Greater Extent than Folic Acid Supplementation. J Nutr. 2018 Jun 1;148(6):885-890. doi: 10.1093/jn/nxy057. PMID: 29878267.
- Taylor MJ, Carney S, Geddes J, et al. Folate for depressive disorders. Cochrane Database Syst Rev 2003;(2):CD003390. PMID: 12804463; DOI: 10.1002/14651858.CD003390.
- McRae MP. J Chiropr Med. 2009 Mar;8(1):15-24. High-dose folic acid supplementation effects on endothelial function and blood pressure in hypertensive patients: a meta-analysis of randomized controlled clinical trials. PMID: 19646382; PMCID:PMC2697578; DOI: 10.1016/j.jcm.2008.09.001.
- Schutten JC, Joris PJ, Minović I, et al. Long-term magnesium supplementation improves glucocorticoid metabolism: A post-hoc analysis of an intervention trial. Clin Endocrinol (Oxf). 2021 Feb;94(2):150-157. doi: 10.1111/cen.14350. Epub 2020 Oct 26. PMID: 33030273; PMCID: PMC7821302.
- Cheung MM, Dall RD, Shewokis PA, et al. The effect of combined magnesium and vitamin D supplementation on vitamin D status, systemic inflammation, and blood pressure: A randomized double-blinded controlled trial. Nutrition. 2022 Jul-Aug;99-100:111674. doi: 10.1016/j.nut.2022.111674. Epub 2022 Apr 1. PMID: 35576873.
- Kwon S, Judson MA. Clinical Pharmacology in Sarcoidosis: How to Use and Monitor Sarcoidosis Medications. J Clin Med. 2024 Feb 22;13(5):1250. doi: 10.3390/jcm13051250. PMID: 38592130; PMCID: PMC10932410.
- Dong JY, Xun P, He K, et al. Magnesium intake and risk of type 2 diabetes: meta-analysis of prospective cohort studies. Diabetes Care. 2011;34(9):2116-22. PMID: 21868780; PMCID: PMC3161260; DOI: 10.2337/dc11-0518.
- Swain R, Kaplan-Machlis B. Magnesium for the next millennium. South Med J 1999;92:1040-7. PMID: 10586828.
- Larsson SC, Wolk A. Magnesium intake and risk of type 2 diabetes: a meta-analysis. J Intern Med 2007;262:208-14. PMID: 17645588.
- Mooren FC, Krüger K, Völker K, et al. Oral magnesium supplementation reduces insulin resistance in non-diabetic subjects – a double-blind, placebo-controlled, randomized trial. Diabetes Obes Metab 2011;13:281-4. PMID: 21205110; DOI: 10.1111/j.1463-1326.2010.01332.x.
- Lasserre B, Spoerri M, Moullet V, et al. Should magnesium therapy be considered for the treatment of coronary heart disease? II. Epidemiological evidence in outpatients with and without coronary heart disease. Magnes Res 1994;7:145-53. PMID: 7999529.
- Aydin H, Deyneli O, Yavuz D, et al. Short-Term Oral Magnesium Supplementation Suppresses Bone Turnover in Postmenopausal Osteoporotic Women. Biol Trace Elem Res. 2010;133(2):136-43. PMID: 19488681; DOI: 10.1007/s12011-009-8416-8.
- Rayssiguier Y. Role of magnesium and potassium in the pathogenesis of arteriosclerosis. Magnesium. 1984;3(4-6):226-38. PMID: 6399344.
- Eby GA, Eby KL. Rapid recovery from major depression using magnesium treatment. Med Hypotheses. 2006;67(2):362-70. doi: 10.1016/j.mehy.2006.01.047. Epub 2006 Mar 20. PMID: 16542786.
- Naggar VF, Khalil SA, Gouda MW. Effect of concomitant administration of magnesium trisilicate on GI absorption of dexamethasone in humans. J Pharm Sci. 1978;67:1029-30. PMID: 207854.
- Quamme GA. Renal handling of magnesium: drug and hormone interactions. Magnesium. 1986;5(5-6):248-72. PMID: 3543513.
- Dokoohaki S, Ghareghani M, Ghanbari A, et al. Corticosteroid therapy exacerbates the reduction of melatonin in multiple sclerosis. Steroids. 2017;128:32-36. PMID: 29061489; DOI: 10.1016/j.steroids.2017.10.006
- Cole JL. Steroid-Induced Sleep Disturbance and Delirium: A Focused Review for Critically Ill Patients. Fed Pract. 2020 Jun;37(6):260-267. PMID: 32669778; PMCID: PMC7357890.
- Posadzki PP, Bajpai R, Kyaw BM, et al. Melatonin and health: an umbrella review of health outcomes and biological mechanisms of action. BMC Med. 2018;16(1):18. PMID: 29397794; PMCID: PMC5798185; DOI: 10.1186/s12916-017-1000-8.
- Hansen MV, Halladin NL, Rosenberg J, et al. Melatonin for pre- and postoperative anxiety in adults. Cochrane Database Syst Rev. 2015(4):CD009861. PMID: 25856551; DOI: 10.1002/14651858.CD009861.pub2.
- Brusco LI, Fainstein I, Marquez M, et al. Effect of melatonin in selected populations of sleep-disturbed patients. Biol Signals Recept 1999;8:126-31. PMID: 10085474; DOI: 10.1159/000014580.
- Dollins AB, Zhdanova IV, Wurtman RJ, et al. Effect of inducing nocturnal serum melatonin concentrations in daytime on sleep, mood, body temperature, and performance. Proc Natl Acad Sci USA 1994;91:1824-8. PMID: 8127888; PMCID: PMC43256.
- Zhdanova IV, Wurtman RJ, Lynch HJ, et al. Sleep-inducing effects of low doses of melatonin ingested in the evening. Clin Pharmacol Ther 1995;57:552-8. PMID: 7768078; DOI: 10.1016/0009-9236(95)90040-3.
- Brzezinski A. Melatonin in humans. N Engl J Med 1997;336:186-95. PMID: 8988899; DOI: 10.1056/NEJM199701163360306.
- Lissoni P, Tancini G, Barni S, et al. The pineal hormone melatonin in hematology and its potential efficacy in the treatment of thrombocytopenia. Recenti Prog Med 1996;87:582-5. PMID: 9066251.
- Grossman E, Laudon M, Zisapel N. Effect of melatonin on nocturnal blood pressure: meta-analysis of randomized controlled trials. Vasc Health Risk Manag. 2011;7:577-84. PMID: 21966222; PMCID: PMC3180511; DOI: 10.2147/VHRM.S24603.
- Demisch L, Demisch K, Nickelsen T. Influence of dexamethasone on nocturnal melatonin production in healthy adult subjects. J Pineal Res 1987;5:317-22. doi: 10.1111/j.1600-079x.1988.tb00657.x. PMID: 3404401.
- Xiang D, Zhang Q, Wang YT. Effectiveness of niacin supplementation for patients with type 2 diabetes: A meta-analysis of randomized controlled trials. Medicine (Baltimore). 2020 Jul 17;99(29):e21235. doi: 10.1097/MD.0000000000021235. PMID: 32702899; PMCID: PMC7373507.
- Azimi Zangabad E, Shomali T, Roshangar L. Effects of pharmacological doses of niacin on subacute glucocorticoid-induced testicular damage in rats. Pharmacol Res Perspect. 2023 Oct;11(5):e01128. doi: 10.1002/prp2.1128. PMID: 37589322; PMCID: PMC10433454.
- Safaei N, Shomali T, Taherianfard M. Niacin Ameliorates Lipid Disturbances due to Glucocorticoid Administration in Rats. Iran J Basic Med Sci. 2012 Jul;15(4):997-1002. PMID: 23493662; PMCID: PMC3586902.
- Mirzaaghasi S, Froushani SMA. Immunomodulatory Effects of Combined Nicotinic Acid and Prednisolone in Adjuvant-induced Arthritis. Antiinflamm Antiallergy Agents Med Chem. 2023;22(2):104-112. doi: 10.2174/0118715230264101230925060355. PMID: 37845835.
- Garg A, Grundy SM. Nicotinic acid as therapy for dyslipidemia in non-insulin-dependent diabetes mellitus. JAMA 1990;264:723-6. PMID: 2374275.
- ASHP Therapeutic Position Statement on the safe use of niacin in the management of dyslipidemias. American Society of Health-System Pharmacists Therapeutic Position Statement. Am J Health Syst Pharm 1997;54:2815-9. PMID: 9428952.
- Shenfield GM, Knowles GK, Thomas N, Paterson JW. Potassium supplements in patients treated with corticosteroids. Br J Dis Chest. 1975 Jul;69:171-6. doi: 10.1016/0007-0971(75)90076-5. PMID: 1201184.
- Odermatt A. Corticosteroid-dependent hypertension: environmental influences. Swiss Med Wkly. 2004 Jan 10;134(1-2):4-13. doi: 10.4414/smw.2004.10372. PMID: 14745661.
- Nesbitt LT Jr. Minimizing complications from systemic glucocorticosteroid use. Dermatol Clin. 1995 Oct;13(4):925-39. PMID: 8785896.
- Aburto NJ, Hanson S, Gutierrez H, et al. Effect of increased potassium intake on cardiovascular risk factors and disease: systematic review and meta-analyses. BMJ. 2013;346:f1378. PMID: 23558164; PMCID: PMC4816263; DOI: 10.1136/bmj.f1378.
- Whelton PK, He J, Cutler JA, et al. Effects of oral potassium on blood pressure. Meta-analysis of randomized controlled clinical trials. Meta-analysis of randomized controlled clinical trials. JAMA 1997;277:1624-32. PMID: 9168293.
- van Bommel E, Cleophas T. Potassium treatment for hypertension in patients with high salt intake: a meta-analysis. Int J Clin Pharmacol Ther. 2012;50(7):478-82. PMID: 22541753; DOI: 10.5414/CP201724.
- Bazzano LA, Green T, Harrison TN, et al. Curr Hypertens Rep. 2013 Dec;15(6):694-702. PMID: 24091874; PMCID: PMC4366416; DOI: 10.1007/s11906-013-0390-z.
- Adebamowo SN, Spiegelman D, Willett WC, et al. Association between intakes of magnesium, potassium, and calcium and risk of stroke: 2 cohorts of US women and updated meta-analyses. Am J Clin Nutr. 2015;101(6):1269-77. PMID: 25948665; PMCID: PMC4441806; DOI: 10.3945/ajcn.114.100354.
- Buist RA. Drug-Nutrient Interactions–An Overview. Int Clin Nutr Rev. 1984;4(3):114-121.
- Thelkeld DS, ed. Hormones, Adrenal Cortical Steroids, Glucocorticoids. In Facts and Comparisons Drug Information. St. Louis, MO: Facts and Comparisons, Apr 1991, 128b.
- Garabedian-Ruffalo SM, Ruffalo RL. Drug and nutrient interactions. Am Fam Physician. 1986 Feb;33(2):165-74. PMID: 3946125.
- Frey FJ, Odermatt A, Frey BM. Glucocorticoid-mediated mineralocorticoid receptor activation and hypertension. Curr Opin Nephrol Hypertens. 2004 Jul;13(4):451-8. doi: 10.1097/01.mnh.0000133976.32559.b0. PMID: 15199296.
- Guo M, Zhang J. Vitamin B2 Prevents Glucocorticoid-Caused Damage of Blood Vessels in Osteonecrosis of the Femoral Head. Biomed Res Int. 2022 Jul 6;2022:4006184. doi: 10.1155/2022/4006184. PMID: 35845964; PMCID: PMC9279053.
- Menezes RR, Godin AM, Rodrigues FF, Coura GME, Melo ISF, Brito AMS, Bertollo CM, Paulino TP, Rachid MA, Machado RR, Coelho MM. Thiamine and riboflavin inhibit production of cytokines and increase the anti-inflammatory activity of a corticosteroid in a chronic model of inflammation induced by complete Freund’s adjuvant. Pharmacol Rep. 2017 Oct;69(5):1036-1043. doi: 10.1016/j.pharep.2017.04.011. Epub 2017 Apr 23. PMID: 28958614.
- Sperduto RD, Hu TS, Milton RC, et al. The Linxian cataract studies. Two nutrition intervention trials. Arch Ophthalmol. 1993;111:1246-53. PMID: 8363468.
- Foy H, Kondi A, Verjee ZH. Relation of riboflavin deficiency to corticosteroid metabolism and red cell hypoplasia in baboons. J Nutr. 1972 Apr;102(4):571-82. doi: 10.1093/jn/102.4.571. PMID: 4622279.
- Nakamura T, Nomoto N, Yagi R, Oya N. Metabolic vitamin B complex deficiency due to the administration of glucocorticoid. J Vitaminol (Kyoto). 1970 Jun 10;16(2):89-98. doi: 10.5925/jnsv1954.16.89. PMID: 5432880.
- Fujii T, Salanti G, Belletti A, et al. Effect of adjunctive vitamin C, glucocorticoids, and vitamin B1 on longer-term mortality in adults with sepsis or septic shock: a systematic review and a component network meta-analysis. Intensive Care Med. 2022 Jan;48(1):16-24. doi: 10.1007/s00134-021-06558-0. Epub 2021 Nov 9. PMID: 34750650; PMCID: PMC8724116.
- Moskowitz A, Yankama T, Andersen LW, Huang DT, Donnino MW, Grossestreuer AV; ACTS Clinical Trial Investigators. Ascorbic Acid, Corticosteroids and Thiamine in Sepsis (ACTS) protocol and statistical analysis plan: a prospective, multicentre, double-blind, randomised, placebo-controlled clinical trial. BMJ Open. 2019 Dec 17;9(12):e034406. doi: 10.1136/bmjopen-2019-034406. PMID: 31852712; PMCID: PMC6937040.
- Cumming RG, Mitchell P, Smith W. Diet and cataract: the Blue Mountains Eye Study. Ophthalmology. 2000;10:450-6. PMID: 10711880.
- Alaei Shahmiri F, Soares MJ, Zhao Y, et al. High-dose thiamine supplementation improves glucose tolerance in hyperglycemic individuals: a randomized, double-blind cross-over trial. Eur J Nutr. 2013 Oct;52(7):1821-4. PMID: 23715873; DOI: 10.1007/s00394-013-0534-6.
- Alaei-Shahmiri F, Soares MJ, Zhao Y, et al. The impact of thiamine supplementation on blood pressure, serum lipids and C-reactive protein in individuals with hyperglycemia: a randomised, double-blind cross-over trial. Diabetes Metab Syndr. 2015 Apr 29. pii: S1871-4021(15)00042-9. PMID: 25982678; DOI: 10.1016/j.dsx.2015.04.014.
- Evans JR, Lawrenson JG. Antioxidant vitamin and mineral supplements for slowing the progression of age-related macular degeneration. Cochrane Database Syst Rev. 2023 Sep 13;9(9):CD000254. doi: 10.1002/14651858.CD000254.pub5. PMID: 37702300; PMCID: PMC10498493.
- Hunt TK, Ehrlich HP, Garcia JA, et al. Effect of vitamin A on reversing the inhibitory effect of cortisone on healing of open wounds in animals and man. Ann Surg 1969;170:633-41. doi: 10.1097/00000658-196910000-00014. PMID: 5387992; PMCID: PMC1387785.
- Shenai JP, Mellen BG, Chytil F. Vitamin A status and postnatal dexamethasone treatment in bronchopulmonary dysplasia. Pediatrics 2000;106:547-53. doi: 10.1542/peds.106.3.547. PMID: 10969101.
- Georgieff MK, Radmer WJ, Sowell AL. The effect of glucocorticosteroids on serum, liver, and lung vitamin A and retinyl ester concentrations. J Pediatr Gastroenterol Nutr 1991;13:376-82. doi: 10.1097/00005176-199111000-00007. PMID: 1779311.
- Vitamin A and glucocorticoid biosynthesis. Nutr Rev. 1970 Jul;28(7):190-2. doi: 10.1111/j.1753-4887.1970.tb06223.x. PMID: 4916138.
- Biyong EF, Alfos S, Dumetz F, et al. Dietary vitamin A supplementation prevents early obesogenic diet-induced microbiota, neuronal and cognitive alterations. Int J Obes (Lond). 2021 Mar;45(3):588-598. doi: 10.1038/s41366-020-00723-z. Epub 2020 Nov 22. PMID: 33223517.
- Lourdudoss C, Hafström I, Frostegård J, et al. The association between diet and glucocorticoid treatment in patients with SLE. Lupus Sci Med. 2016 Jan 27;3(1):e000135. doi: 10.1136/lupus-2015-000135. PMID: 26848399; PMCID: PMC4731837.
- Dakshinamurti S, Dakshinamurti K. Antihypertensive and neuroprotective actions of pyridoxine and its derivatives. Can J Physiol Pharmacol. 2015;93(12):1083-90. PMID: 26281007; DOI: 10.1139/cjpp-2015-0098.
- Aybak M, Sermet A, Ayyildiz MO, et al. Effect of oral pyridoxine hydrochloride supplementation on arterial blood pressure in patients with essential hypertension. Arzneimittelforschung. 1995 Dec;45(12):1271-3. PMID: 8595083.
- Sur S, Camara M, Buchmeier A, et al. Double-blind trial of pyridoxine (vitamin B6) in the treatment of steroid-dependent asthma. Ann Allergy 1993;70:147-52. PMID: 8430923.
- McCarty MF. High-dose pyridoxine as an ‘anti-stress’ strategy. Med Hypotheses. 2000 May;54(5):803-7. doi: 10.1054/mehy.1999.0955. PMID: 10859691.
- Compton MM, Cidlowski JA. Vitamin B6 and glucocorticoid action. Endocr Rev. 1986 May;7(2):140-8. doi: 10.1210/edrv-7-2-140. PMID: 2873032.
- Fujii T, Salanti G, Belletti A, et al. Effect of adjunctive vitamin C, glucocorticoids, and vitamin B1 on longer-term mortality in adults with sepsis or septic shock: a systematic review and a component network meta-analysis. Intensive Care Med. 2022 Jan;48(1):16-24. doi: 10.1007/s00134-021-06558-0. Epub 2021 Nov 9. PMID: 34750650; PMCID: PMC8724116.
- Fogarty A, Lewis SA, Scrivener SL, Antoniak M, Pacey S, Pringle M, Britton J. Corticosteroid sparing effects of vitamin C and magnesium in asthma: a randomised trial. Respir Med. 2006 Jan;100(1):174-9. doi: 10.1016/j.rmed.2005.03.038. Epub 2005 Apr 26. PMID: 16338599.
- McRae, MP. Vitamin C supplementation lowers serum low-density lipoprotein cholesterol and triglycerides: a meta-analysis of 13 randomized controlled trials. J Chiropr Med 2008;7(2):48-58. PMID: 19674720; PMCID: PMC2682928; DOI: 10.1016/j.jcme.2008.01.002.
- Alster TS, West TB. Effect of topical vitamin C on postoperative carbon dioxide laser resurfacing erythema. Dermatol Surg. 1998 Mar;24(3):331-4. doi: 10.1111/j.1524-4725.1998.tb04163.x. PMID: 9537007.
- Deved V, Poyah P, James MT, et al. Ascorbic acid for anemia management in hemodialysis patients: a systematic review and meta-analysis. Am J Kidney Dis. 2009 Dec;54(6):1089-97. DOI: 10.1053/j.ajkd.2009.06.040. PMID: 19783342.
- Buist RA. Drug-Nutrient Interactions–An Overview. Int Clin Nutr Rev. 1984;4(3):114-121.
- Humphrey MB, Russell L, Danila MI, et al. 2022 American College of Rheumatology Guideline for the Prevention and Treatment of Glucocorticoid-Induced Osteoporosis. Arthritis Rheumatol. 2023 Dec;75(12):2088-2102. doi: 10.1002/art.42646. Epub 2023 Oct 16. PMID: 37845798.
- Messina OD, Vidal LF, Wilman MV, et al. Management of glucocorticoid-induced osteoporosis. Aging Clin Exp Res. 2021 Apr;33(4):793-804. doi: 10.1007/s40520-021-01823-0. Epub 2021 Mar 22. PMID: 33751462.
- Skversky AL, Kumar J, Abramowitz MK, et al. Association of glucocorticoid use and low 25-hydroxyvitamin D levels: results from the National Health and Nutrition Examination Survey (NHANES): 2001-2006. J Clin Endocrinol Metab. 2011 Dec;96(12):3838-45. doi: 10.1210/jc.2011-1600. Epub 2011 Sep 28. PMID: 21956424.
- Homik J, Suarez-Almazor ME, Shea B, et al. Calcium and vitamin D for corticosteroid-induced osteoporosis. Cochrane Database Syst Rev. 2000;(2):CD000952. PMID: 10796394; DOI: 10.1002/14651858.CD000952.
- Briot K, Roux C. Glucocorticoid-induced osteoporosis. RMD Open. 2015 Apr 8;1(1):e000014. PMID: 26509049; PMCID: PMC4613168; DOI: 10.1136/rmdopen-2014-000014.
- Hoes JN, Bultink IE, Lems WF. Management of osteoporosis in rheumatoid arthritis patients. Expert Opin Pharmacother. 2015 Mar;16(4):559-71. PMID: 25626121; DOI: 10.1517/14656566.2015.997709.
- Mohn ES, Kern HJ, Saltzman E, et al. Evidence of Drug-Nutrient Interactions with Chronic Use of Commonly Prescribed Medications: An Update. Pharmaceutics. 2018;10(1)pii: E36. PMID: 29558445; PMCID: PMC5874849; DOI: 10.3390/pharmaceutics10010036.
- Richy F, Ethgen O, Bruyere O, Reginster JY. Efficacy of alphacalcidol and calcitriol in primary and corticosteroid-induced osteoporosis: a meta-analysis of their effects on bone mineral density and fracture rate. Osteoporos Int. 2004;15(4):301-310. PMID: 14740153; DOI: 10.1007/s00198-003-1570-5.
- de Nijs RN, Jacobs JW, Algra A, et al. Prevention and treatment of glucocorticoid-induced osteoporosis with active vitamin D3. Osteoporos Int. 2004;15(8):589-602. PMID: 15138667; DOI: 10.1007/s00198-004-1614-5.
- Amin S, LaValley MP, Simms RW, et al. The comparative efficacy of drug therapies used for the management of corticosteroid-induced osteoporosis: a meta-regression. J Bone Miner Res. 2002;17(8):1512-1526. PMID: 12162505; DOI: 10.1359/jbmr.2002.17.8.1512.
- Caan B, Neuhouser M, Aragaki A, et al. Calcium plus vitamin D supplementation and the risk of postmenopausal weight gain. Arch Intern Med. 2007;167:893-902. PMID: 17502530; DOI: 10.1001/archinte.167.9.893.
- Schnatz PF, Jiang X, Aragaki AK, et al. Effects of Calcium, Vitamin D, and Hormone Therapy on Cardiovascular Disease Risk Factors in the Women’s Health Initiative: A Randomized Controlled Trial. Obstet Gynecol. 2017;129(1):121-129. PMID: 27926633; PMCID: PMC5177479; DOI: 10.1097/AOG.0000000000001774.
- Ford JA, MacLennan GS, Avenell A, et al; RECORD Trial Group. Am J Clin Nutr. 2014 Sep;100(3):746-55. PMID: 25057156; DOI: 10.3945/ajcn.113.082602.
- Van Staa TP, Leufkens HG, Cooper C. The Epidemiology of Corticosteroid-Induced Osteoporosis: A Meta-analysis. Osteoporos Int. 2002;13:777–787. doi: 10.1007/s001980200108. PMID: 12378366.
- Hahn TJ, Halstead LR, Baran DT. Effects off short term glucocorticoid administration on intestinal calcium absorption and circulating vitamin D metabolite concentrations in man. J Clin Endocrinol Metab. 1981;52:111–115. doi: 10.1210/jcem-52-1-111. PMID: 6969728
- Buckley LM, Leib ES, Cartularo KS, et al. Calcium and vitamin D3 supplementation prevents bone loss in the spine secondary to low-dose corticosteroids in patients with rheumatoid arthritis. A randomized, double-blind, placebo-controlled trial. Ann Intern Med. 1996;125:961–968. doi: 10.7326/0003-4819-125-12-199612150-00004. PMID: 8967706.
- Adachi JD, Bensen WG, Bianchi F, et al. Vitamin D and calcium in the prevention of corticosteroid induced osteoporosis: A 3 year followup. J. Rheumatol. 1996;23:995–1000. PMID: 8782129
- Bijlsma JW, Raymakers JA, Mosch C, et al. Effect of oral calcium and vitamin D on glucocorticoid-induced osteopenia. Clin Exp Rheumatol. 1988;6:113–119. PMID: 3180536 Google Scholar
- Ringe JD, Cöster A, Meng T, et al. Treatment of glucocorticoid-induced osteoporosis with alfacalcidol/calcium versus vitamin D/calcium. Calcif Tissue Int. 1999;65:337–340. doi: 10.1007/s002239900708. PMID: 10485988 Google Scholar
- Trovato A, Nuhlicek DN, Midtling JE. Drug-nutrient interactions. Am Family Phys 1991;44:1651-8. PMID: 1950962.
- Chesney RW, Mazess RB, Hamstra AJ, et al. Reduction of serum-1,25-dihydroxyvitamin-D, in children receiving glucocorticoids. Lancet 1978;ii:1123-5. PMID: 82684.
- Nielsen HK, Eriksen EF, Storm T, Mosekilde K. The effects of short-term, high-dose prednisone on the nuclear uptake of 1,25-dihydroxyvitamin D3 in monocytes from normal human subjects. Metabolism 1988;37:109-14. doi: 10.1016/s0026-0495(98)90002-6. PMID: 2828820.
- Avioli LV. Serum 25-hydroxyvitamin D concentrations in patients receiving chronic corticosteroid therapy. J Lab Clin Med 1977;23:399-404. PMID: 886226.
- Shikano K, Kaneko K, Kawazoe M, et al. Efficacy of Vitamin K2 for Glucocorticoid-induced Osteoporosis in Patients with Systemic Autoimmune Diseases. Intern Med. 2016;55(15):1997-2003. doi: 10.2169/internalmedicine.55.6230. Epub 2016 Aug 1. PMID: 27477405.
- Tanaka I, Oshima H. Vitamin K2 as a potential therapeutic agent for glucocorticoid-induced osteoporosis. Clin Calcium. 2007 Nov;17(11):1738-44. Japanese. PMID: 17982195.
- Zhang YL, Yin JH, Ding H, et al. Vitamin K2 Prevents Glucocorticoid-induced Osteonecrosis of the Femoral Head in Rats. Int J Biol Sci. 2016;12(4):347-58. doi: 10.7150/ijbs.13269. PMID: 27019620; PMCID: PMC4807155.
- Chen L, Shi X, Weng SJ, et al. Vitamin K2 Can Rescue the Dexamethasone-Induced Downregulation of Osteoblast Autophagy and Mitophagy Thereby Restoring Osteoblast Function In Vitro and In Vivo. Front Pharmacol. 2020 Aug 11;11:1209. doi: 10.3389/fphar.2020.01209. PMID: 32848799; PMCID: PMC7431688.
- Petrilli MA, Kranz TM, Kleinhaus K, et al. Front Pharmacol. 2017 Jun 30;8:414. PMID: 28713269; PMCID: PMC5492454; DOI: 10.3389/fphar.2017.00414.
- Nowak G, Siwek M, Dudek D, et al. Pol J Pharmacol. 2003 Nov-Dec;55(6):1143-7. PMID: 14730113.
- Strause L, Saltman P, Smith KT, et al. J Nutr. 1994;124:1060-4. PMID: 8027856; DOI: 10.1093/jn/124.7.1060.
- Hyun TH, Barrett-Connor E, Milne DB. Am J Clin Nutr. 2004 Sep;80(3):715-21. PubMed PMID: 15321813; DOI: 10.1093/ajcn/80.3.715.
- Dreno B, Trossaert M, Boiteau HL, et al. Acta Derm Venereol. 1992;72:250-2. PMID: 1357876.
- Lazzerini M, Wanzira H. Cochrane Database Syst Rev. 2016 Dec 20;12:CD005436. PMID: 27996088; PMCID: PMC5450879; DOI: 10.1002/14651858.CD005436.pub5.
- Buist RA. Drug-Nutrient Interactions–An Overview. Int Clin Nutr Rev. 1984;4(3):114-121.
- Morais JBS, Cruz KJC, de Oliveira ARS, et al. Association Between Parameters of Cortisol Metabolism, Biomarkers of Minerals (Zinc, Selenium, and Magnesium), and Insulin Resistance and Oxidative Stress in Women with Obesity. Biol Trace Elem Res. 2023 Dec;201(12):5677-5691. doi: 10.1007/s12011-023-03639-7. Epub 2023 Apr 11. PMID: 37039941.
- Takeda A, Tamano H, Ogawa T, et al. Significance of serum glucocorticoid and chelatable zinc in depression and cognition in zinc deficiency. Behav Brain Res. 2012 Jan 1;226(1):259-64. doi: 10.1016/j.bbr.2011.09.026. Epub 2011 Sep 19. PMID: 21946308.
- Takeda A, Tamano H. Insight into zinc signaling from dietary zinc deficiency. Brain Res Rev. 2009 Dec 11;62(1):33-44. doi: 10.1016/j.brainresrev.2009.09.003. Epub 2009 Sep 10. PMID: 19747942.
- Prasad AS. Clinical, endocrinologic, and biochemical effects of zinc deficiency. Spec Top Endocrinol Metab. 1985;7:45-76. PMID: 3914098.
An article by Emily Mohn called Evidence of Drug–Nutrient Interactions with Chronic Use of Commonly Prescribed Medications showed that for just calcium, vitamin D, potassium/sodium and chromium alone, there were at least 97 human studies documenting that this happens. Prednisone causes nutrient depletion of these five plus more nutrients and replenishment is necessary.
That’s why Dr. Megan invented Nutranize Zone for people on prednisone.
Is prednisone making you miserable, too?
Find replenishment
Dr. Megan created a supplement designed especially for people taking prednisone.*
Related Posts
-
9+ Nutrients Depleted by Prednisone
Prednisone steals over nine critical nutrients from the body. This nutrient depletion is responsible for... -
I’m on Prednisone: Can I Take Vitamins?
You might be asking, is it okay to take vitamins with prednisone? Maybe you’re afraid... -
WHO Should Use Prednisone for COVID-19?
Corticosteroids Save Lives Prednisone and its sisters, the corticosteroids, are the only drugs shown to...